Triumvira Immunologics Funding: $100M Raised, Series A
Triumvira Immunologics is based in Cambridge, MA. It has raised $100M in total funding. Latest round: Series A.
Triumvira Immunologics funding overview
Triumvira Immunologics is based in Cambridge, MA. Triumvira Immunologics has raised $100M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in January 2021. The round record for Triumvira Immunologics runs through 2021; nothing later has been disclosed. Investors on record include Leaps on Bear, Northbound Ventures, Bloomberg, Fifa Biotech, Oceanvine, C3i and 1 others. 7 distinct backers are named across the disclosed rounds.
Triumvira Immunologics at a glance
Total raised
$100M
Latest round
Series A
Latest round date
January 2021
Headquarters
Cambridge, MA
Notable investors
Leaps on Bear, Northbound Ventures, Bloomberg, Fifa Biotech, Oceanvine, C3i, Hayward Security
Frequently asked about Triumvira Immunologics funding
How much has Triumvira Immunologics raised?
Triumvira Immunologics has raised $100M in total disclosed funding across the rounds on record.
Who has invested in Triumvira Immunologics?
Leaps on Bear, Northbound Ventures, Bloomberg, Fifa Biotech, Oceanvine, C3i are named among the investors backing Triumvira Immunologics.
What was the latest Triumvira Immunologics funding round?
The most recent disclosed round is a Series A, announced in January 2021.
Where is Triumvira Immunologics based?
Triumvira Immunologics is based in Cambridge, MA.
When did Triumvira Immunologics last raise?
The last disclosed Triumvira Immunologics round closed in January 2021 at Series A.
We update the Triumvira Immunologics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Cambridge and their backers are listed below.
